C&R Research Inc. (KOSDAQ:359090)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,978.00
-1.00 (-0.05%)
At close: Sep 3, 2026

C&R Research Revenue

C&R Research had revenue of 17.78B KRW in the quarter ending June 30, 2026, with 5.01% growth. This brings the company's revenue in the last twelve months to 63.55B, down -1.69% year-over-year. In the year 2025, C&R Research had annual revenue of 64.98B with 8.87% growth.

Revenue (ttm)
63.55B
Revenue Growth
-1.69%
P/S Ratio
0.36
Revenue / Employee
124.60M
Employees
510
Market Cap
22.77B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202564.98B5.29B8.87%
Dec 31, 202459.69B4.59B8.32%
Dec 31, 202355.10B6.63B13.68%
Dec 31, 202248.47B5.30B12.28%
Dec 31, 202143.17B15.97B58.70%
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
HLB bioStep73.96B
DreamCIS73.28B
DT&CRO CO.49.00B
Kolmar BioTech40.30B
BioInfra25.62B
P&K Skin Research Center22.56B
Penetrium Bioscience9.74B
Curachem6.02B
Revenue Rankings